Home / Market News / $SGRY
fiscal.ai Corporate Catalyst Impact 95/100 ● negative

Surgery Partners Rejects $28 Per Share Bid from UnitedHealth Group

Nov 9, 2026, 7:03 PM UTC · Primary ticker $SGRY

Surgery Partners rejected an acquisition offer from UnitedHealth Group, citing regulatory risks and potential delays. Instead, Surgery Partners opted to proceed with an amended merger agreement with HealthSpan Partners, indicating a clear strategic direction away from the larger suitor.

Surgery Partners rejected a $28 per share acquisition bid from UnitedHealth Group, citing significant regulatory risks and potential delays. This decision is a major corporate catalyst for SGRY, as it foregoes a potentially higher valuation from a major player. Instead, Surgery Partners is proceeding with an amended merger agreement with HealthSpan Partners, suggesting a preference for a less complex integration. For traders, this creates short-term uncertainty for SGRY, as the market may react negatively to the rejection of a premium offer, potentially leading to a price correction. UNH's involvement appears to be a non-event for its stock, as they declined to comment and the bid was rejected, indicating no immediate strategic shift or financial outlay.

$SGRY negative Rejected higher bid, potential for lower valuation
$UNH neutral Bid rejected, no immediate impact on core business
Source: fiscal.ai
Join the waitlist for full signal validation →

Not financial advice. AI-generated analysis for informational purposes only.